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Abstract 
The Fragile X Syndrome and Infantile Autism: 
A Prevalence Study 
A thesis submitted to the Yale University School of Medicine in 
partial fulfillment of the requirements for the degree of Doctor 
of Medicine . 
by Brian Herb Annex 
Submitted: Febuary, 1985 
The fragile X syndrome is a form of X-linked mental 
retardation that may be identified by special cytogenetic 
techniques. The fragile X syndrome is associated with mental 
retardation and macroorchidism, but other clinical features have 
been reported. Infantile autism is a syndrome of severe 
behavioral abnormalities that are manifested by 30 months of 
age. Infantile autism is frequently associated with mental 
retardation and is an etio1ogica 11y heterogeneous disorder. 
The fragile X syndrome has been implicated as the etiology 
for both the mental retardation and infantile autism in several 
males recently reported. In these reports there was speculation 
that the fragile X syndrome with features of infantile autism 
could explain part of the recognized male excess in infantile 
autism and that a high frequency of association between these 
disorders may exist. 
This study was designed to determine the prevalence of the 
fragile X syndrome in a population of autistic mentally retarded 
males, since no studies of this type have been reported. Four of 
47 males with infantile autism and mental retardation were found 
to have the fragile X syndrome giving a prevalence of 8.5%. This 
finding suggests that a significant proportion of autistic 
mentally retarded males may be affected by the fragile X 
syndrome. The significance of this finding and recommendations 
for the use of fragile X testing in males with infantile autism 
are discussed. 
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CHAPTER ONE: Fragile X_ Syndrome 
Part A_: Nonspecific X-l inked Mental Retardation 
In 1938, Dr. L. S. Penrose [1] published the results of a 
large survey of the mentally retarded population in Colchester, 
England, in which he found significantly more affected males than 
females. As recently as 1963, he attributed this finding to a 
variety of social factors, not to any influence of the X 
chromosome [2], This was the accepted theory for many years. 
In 1972, Lehrke [3] also found an excess of mentally retarded 
males in his review of the literature and his own data derived 
from family studies of patients in the institutions for the 
mentally retarded in Wisconsin. Lehrke [3] postulated that 
X-linked genes were responsible for this male excess and perhaps 
a large proportion of all mental retardation. This hypothesis 
received strong criticism from authors [4,5] who continued to 
primarily use Penrose's [2] explanation. Lehrke [5], however, 
continued to defend his theory. 
At the time of Lehrke's report [3] there were a number of 
reports published of large families in which mental retardation 
appeared to be inherited in an X-linked pattern. Among these 
reports were the families described by Martin & Bell [7] in 1943, 
and Renpenning et al. [8] in 1961. They discussed a form of 
X-linked mental retardation in which the affected persons had no 
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distinct physical abnormalities. This was termed nonspecific 
X-linked mental retardation. 
Part _B: Discovery of a Fragile X. Chromosome 
In 1969, Dr. Herbert A. Lubs, [9] then at the Yale University 
School of Medicine, noted a peculiar secondary constriction on 
the long arm of a C group chromosome in a significant percent of 
the lymphocytes in four mentally retarded males. They were all 
members of a family being studied cytogenetically because of a 
pattern of mental retardation consistent with X-linkage. By use 
of radioactive nucleotide labeling and evaluation of chromosomal 
size and arm ratios, Lubs concluded that this C group chromosome 
was the X chromosome. He went on to identify this secondary 
constriction in some of the obligate carriers. Dr. Lubs had 
identified a form of X-linked mental retardation with a 
cytogenetically identifiable abnormality on the X chromosome. He 
titled this paper, "A Marker X Chromosome." 
Although many mentally retarded persons were being studied 
cytogenetically no similar cases of this marker chromosome were 
reported for a number of years. In 1976, Giraud et al. [10] 
published a report of 18 people with mental retardation and 
structural chromosomal variations. Six of these patients had 
identical chromosomal breaks at the distal end of the X 
chromosome. In 1977, Harvey et al. [11] also confirmed the 
initial studies of Lubs [9], with a report on a total of 14 
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mentally retarded males in four families with this X-chromosome 
abnormality. 
In 1977, Sutherland [12,13] observed that special culture 
cell conditions were needed for reliable cytogenetic detection of 
this X-chromosome abnormaltiy, which he termed the fragile X 
chromosome. In 1979, Sutherland [14] defined a fragile site as a 
specific chromosomal point having four features: 1) it appeared 
as a nonstaining gap usually involving both chromatids; 2) it was 
located at an identical position between and within idividuals; 
3) it showed Mendelian codominant inheritance; and 4) its 
fragility was exhibited as acentric fragments, deleted 
chromosomes, triradial formation, etc.. The terms, fragile X 
chromosome and marker X chromosome, are used by most authors 
interchangably, to describe this site on the the X chromosome. 
Part C: Prevalence 
In 1980, Herbst & Miller [15] reviewed four previously 
published surveys of families with X-linked mental retardation 
and found that 19 out of these 42 families demonstrated the 
fragile X chromosome. The authors used the British Columbia 
Health Surveillance Registry and obtained data, covering a 20 
year period of time, on the number of families in which two or 
more siblings were found to have nonspecific mental retardation. 
They calculated the overall incidence of nonspecific X-linked 
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mental retardation to be 1.83 per 1000 males in the general 
population and estimated that of the fragile X syndrome to be 
0.92 per 1000 males. Similarly in 1983, Fishburn et al. [16] 
restudied the brother pairs ascertained by one of the authors, 
Turner et al. [17], who in 1974, estimated the incidence of 
X-linked mental retardation in New South Wales to be 0.58 per 
1000 males. Cytogenetic studies revealed that 12 of those 54 
brother pairs demonstrated the fragile X chromosome and led to an 
estimate for the incidence of the fragile X syndrome of 0.13 per 
1000 males. 
In 1982 and 1983, eight large studies of the frequency of the 
fragile X chromosome in mentally retarded male populations were 
published [ 18,20-26] (See Table 1 at the end of this chapter). 
Many screened more than two hundred patients and although they 
used different selection criteria, they yielded reasonably 
similar results within the range of 1.7% [18] and 9.2% [20]. Four 
of the eight studies had results between 4% and 6% [21,22,24,25]. 
Two of the eight studies, Blomquist et al. [21] and 
Froster-Iskenius et al. [24] extrapolated the results from their 
institutions to the general population to estimate the frequency 
of the fragile X chromosome to be 0.4 and 0.5 per 1000 males 
respectively. The fragile X syndrome would then be second only 
to Down Syndrome in frequency as a recognized genetic etiology of 
mental retardation [27]. 

Part D: Phenotype 
In the original reports of males with the fragile X syndrome 
no significant physical findings were noted [9-11]. Giraud et 
al. [10] commented only on a subjective impression of "large 
ears" in the affected males. Some authors, Jennings et al. [28] 
and Proops et al. [29], used the eponyms of the Martin & Bell 
Syndrome, Renpenning Syndrome, and marker X syndrome, 
synonomously with nonspecific X-linked mental retardation. 
Indeed, the family which was the subject of the report by Martin 
& Bell [7] was found to have the fragile X chromosome [30]. 
However, the family reported by Renpenning et al. [7] did not to 
have the fragile X chromosome upon retesting [31] and the 
possibility of a diagnostic phenotype appeared. 
In the 1970's, reports in the literature by Escalante et al. 
[32], Turner et al . [33], Cantu et al. [34], and Ruvalcaba et 
al. [35] described a form of X-linked mental retardation that 
was associated with the feature of macroorchidism. In 1978, 
Turner et a 1 . [36] restudied 16 families, some of whom were 
described i n 1975 [33], for the presence o f the fragile X 
chromosome and found it in six o f these families. Furthermore, 
they found that all of the males with the fragile X chromosome 
had macroorchidism, while all the males with normal cytogenetic 
studies had normal testicular size. Reports with similar 
findings also were published in 1979 by Howard-Peebles et al. 
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[37] and Sutherland et al. [38], 
This association between macroorchidism and the fragile X 
chromosome is far from absolute. In 1982, Brondum-Nie1sen et 
al. [22] and Howard-Peebles et al. [39] in 1983, showed that a 
large proportion, 20% and 29% respectively, of the mentally 
retarded males in their institutions had macroorchidism. This 
was determined by using the standards of Prader [40], who 
established the 90th percentile of testicular volume in 
postpubertal males to be between 23 and 25 ml. and any volume 
above that was considered to be ma c r o o r c h i d i sm . Brown et al. 
[19] reported that four out of five males they tested with 
macroorchidism had the fragile X chromosome. Other reports did 
not find as close an association. Brondum-Nielsen et al. [22] 
found that only two of 52 patients with ma c r o o r c h i d i sm had the 
fragile X chromosome. They found within this group that two of 
the 11 patients with profound macroorchidism (>34ml) demonstrated 
the fragile X chromosome. They also tested all 52 males for 
other disorders known to cause mental retardation and 
macroorchidism. Howard-Peebles et al. [39] did find that nearly 
25% of the mentally retarded males with profound macroorchidism 
had the fragile X chromosome, but, they did not test all the 
males in the 25-34 ml range. These frequencies, however, are 
much lower than those reported by Brown et al. [19], 
In 1979, Jacobs et al. [41] reported on six families with 
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X-linked mental retardation. In five of these six families the 
males had macroorchidism. The males in the three families found 
to have the fragile X chromosome did not have macroorchidism and 
in the one family in which the males had macroorchidism the 
authors did not find the fragile X chromosome. Likewise, Herbst 
et al . [42] found that the feature of macroorchidism did not 
distinguish between the fragile X positive or negative males. 
Fryns et al . [23] found that only 6 of 19 patients with the 
fragile X chromosome had macroorchidism. 
In 1983, Carpenter [43] in a review of the literature noted 
that macroorchidism was present in 88% of 120 postpubertal males 
with the fragile X syndrome, but, in only 23% of 34 prepubertal 
males in whom testicular volume was recorded. It would appear 
that macroorchidism is a reliable but not obligatory feature of 
the fragile X syndrome in postpubertal males and not a major 
feature in the young child. This is reflected in the current 
McKusick catalogue [44], in which males with X-linked mental 
retardation, fragile X positive, with or without macroorchidism 
are given the same classification number. 
While much has been written on the feature of macroorchidism 
and the fragile X syndrome, other clinical findings have not 
received as much attention but deserve mention. Carpenter [43] 
reviewed and tabulated the clinical features described in the 252 
affected males with the fragile X syndrome reported in the 
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literature. The IQ of the 70 affected males, in whom it was 
recorded, revealed that 40% had moderate mental retardation (IQ 
35-49) and roughly 28% were in the mild (IQ 50-70) and severe 
(20-34) range. Only a few case reports in the literature [45-47] 
have claimed that the fragile X chromosome exists in males of 
normal intelligence. Carpenter [43] found that other physical 
abnormalities were noted in the males with the fragile X 
syndrome. This included the findings of ear abnormalities, 
strabismus, and abnormalities of the palate. Many other findings 
were also listed but at such low frequencies that they may be 
merely coincidental. 
Part E_: Cytogenetics 
The cytogenetic techniques needed to study the fragile X 
chromosome have been understood for less than ten years. They 
are, however, now well accepted and described in the major 
cytogenetic texts and journals [49,50], 
Seven years passed between the first description of the 
fragile X chromosome by Lubs [9] and the second report by Giraud 
[10]. In 1977, Sutherland [13] was able to explain this time lag 
on the basis of the lymphocyte culture media. He noted that 
expression of the fragile X site was obtained in only one of the 
commercially available media used by the cytogenetic laboratories 
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at that time. 
In 1979, Sutherland [14] found that the media, "Medium 199", 
presumably the one used by Lubs [9] and Giraud [10], was somewhat 
deficient in thymidine and folic acid. The addition of 
relatively low doses of either inhibits the expression of the 
fragile X site. In 1981, Glover [51] and Mattei et al.[52] both 
showed that the inhibitory effects of folate could be overcome by 
methotrexate, a folate antagonist, but the inhibitory effects of 
thymidine could not. Methotrexate acts primarily by inhibiting 
the enzyme dihydrofo1 ate reductase which is required for a one 
carbon transfer, necessary for the generation of the pyrimidine 
precursor, deoxythymidine monophosphate (dTMP), required for DNA 
synthesis [53]. This allowed recognition and confirmation by 
Glover [51] and Tommerup et al. [54] that thymidylate synthetase 
was one likely metabolic site involved in fragile X expression. 
They also discussed the employment of a direct thymidylate 
synthetase inhibitor, 5-f1uorodeoxyuridine (FdU), as yet another 
method of producing the proper conditions for fragile X 
expression, in vitro. 
Many culture variables may be involved in the detection of 
the fragile X chromosome [49] and different cytogenetic 
laboratories have their own preferred methods. The most 
important aspect of the lymphocyte culture conditions is to 
generate a thymidine depleted media. This must be done under 
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conditions 
reproducable 
that allow adequate lymphocyte growth and 
test results . 
are 
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Table 1 
Prevalence studies of the fragile _X syndrome 
in mentally retarded male populations ♦ 
Study author Number Prevalence Feature(s) 
Sutherland (1982) [18] 444 1 . 7% mental retardation 
Carpenter et al.(1982) [20] 65 9.2% mental 
family 
retardation 
history 
Blomquist et al.(1982) [21] 96 4% mental retardation 
Brondum-Nielsen et a 1. 
(1982) [22] 52 4% 
mental retardation 
macroorchidism 
Fry ns et al . ( 1983) [23] 250 3% mental 
family 
retardation 
history 
Froster-Iskenius et al 
(1983) ’[24] 242 6.2% mental retardation 
Kahkonen et al.(1983) [25] 150 4% mental retardation 
macroorchidism 
Jacobs et al.(1983) [26] 234 2% mental retardation 
47 This investigation 8.5% mental retardation 
infantile autism 

CHAPTER TWO: Infantile Autism 
Part A_: Def inition 
In 1943, Dr. Leo Kanner [55] published the original 
description of a group of children with severe developmental 
abnormalities and a unique quality of self-centeredness. He 
termed this syndrome, "early infantile autism." In an extensive 
review on the subject in 1981, DeMyer et a 1. [56] discussed the 
research that changed the consensus view of the syndrome. This 
disorder was originally viewed as a distinct entity. By the time 
of the 1977 meeting of the Professional Advisory Board of the 
National Society for Children and Adults with Autism [57], 
infantile autism had become recognized as a syndrome that could 
be diagnosed by a characteristic group of behavioral signs have a 
variety of associated features (i.e. mental retardation) and 
etiologies (i.e. phenylketonuria). (See Appendix A for the 
descriptions of these behavioral signs.) Much of this 
information was incorporated by the American Psychiatric 
Association as part of the latest edition of their "Diagnostic 
and Statistical Manual of Mental Disorders," DSM-III [58]. This 
was done to allow more consistency in diagnosis and to aid in 
future research on the subject. 
There are six criteria (see Table 2) that are required for a 
person to be diagnosed as having infantile autism, according to 
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the DSM-III [58]. Two of the criteria, onset before 30 months of 
age and an absence of psychotic features, were included to 
distinguish infantile autism from the disorders of schizophrenia, 
mania and other forms of adult and childhood psychosis. Two 
other criteria are a severe lack of responsiveness to others with 
a failure to develop interpersonal relationships and bizarre 
responses to environmental stimuli. The former is the feature 
which Kanner [55] referred to as "autism" (See Appendix A: #2 and 
#4 for a more detailed description). Lastly, two criteria are 
related to disorders in many aspects of the development and use 
of language. 
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Table 2 
DSM-III Criteria for Infantile Autism 
A. Onset before 30 months of age. 
B. Pervasive lack of responsiveness to other people (autism). 
C. Gross deficits in language development. 
D. If speech is present, peculiar speech patterns such as 
immediate and delayed echolalia, metaphorical language, 
pronominal reversal. 
E. Bizarre responses to various aspects of the environment, e.g. 
resistance to change, peculiar interest in or attachments to 
animate or inanimate objects. 
F. Absence of delusions, hallucinations, loosening of 
associations, and incoherence as in schizophrenia. 
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Part B: Prevalence 
In review articles [56,59] the frequently cited prevalence 
figure for infantile autism is 4-5 per 10,000 children, although 
the DSM-III [58] uses a slightly lower figure of 2-4 per 10,000. 
The former figure was found by Wing et al . [60], in 1976 . They 
reviewed in detail several large epidemiologic surveys on the 
subject. These were studies of either the general population or 
of children with a broad range of handicaps and most involved 
both written medical history and personal evaluation by the 
original authors. When these methods were used to establish the 
diagnosis of autism, there was remarkable agreement. One of the 
five studies used only medical histories and offered a lower 
prevalence figure. Although the studies predated the DSM-III 
[58], the criteria used appear to be essentialy the same. Thus, 
the prevalence figure of 4-5 per 10,000 is generally accepted. 
Part C: Genetic Aspects 
The possibility of genetic influences in infantile autism can 
be dated back to the original description by Kanner [55]. Indeed, 
he suggested that an "inborn error" would be needed to explain 
the early age of presentation in this disorder. Some 25 years 
later it was recognized that a 50-fold increased risk for 
developing autism existed for a child with an autistic sibling 
when compared to the general population [61], Despite this fact, 
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reviewers questioned the data used to support the role of genetic 
influences in infantile autism, allowing for the possibility of 
rare mutations [62] or complex polygenic inheritance [62,63] 
which they could not exclude. 
Twin studies have since provided strong support for a role of 
genetic influences in the development of infantile autism. In 
1977, Folstein and Rutter [64] studied 21 sets of same-sexed 
twins in whom at least one met the then accepted criteria for 
autism. They found that four of 11 monozygotic twins were 
concordant for autism compared to none of ten dizygotic twins. 
This result was statistically significant at a p value of 0.055. 
Several years earlier Bartak et al. [65] had found that 
relatives of autistic children demonstrated a spectrum of 
cognitive and language defects, not limited to autism. Using 
this evidence, Folstein and Rutter [64] found that nine of 11 
monozygotic twins were concordant for either a form of cognitive 
defect or autism compared to only one of ten dizygotic sets. 
This result was statistically significant at a much lower p 
value. Although a specific mode of inheritance could not be 
delineated, a genetic influence was suggested. In 1982, a group 
at U.C.L.A. headed by Dr. Edward Ritvo organized the Registry for 
Genetic Studies in Autism [66]. They reported recently [67] on 33 
sets of monozygotic twins with all but one pair being concordant 
for autism. Among the dizygotic sets there were only three out 
of 24 concordant for autism. This strongly supports the findings 
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of Folstein and Rutter [64], 
One often overlooked piece of epidemiologic data concerning 
infantile autism has been the consistent finding of a large 
excess of affected males. In 1975 , Ando et al. [68] found the 
male to female ratio in children with infantile autism to be 
markedly different from that found in other forms of mental 
retardation. In 1981, Tsai et al. [69] cited no less than eight 
studies, between 1966 and 1979 , that showed this ratio to be in 
the range of 3:1 to 5:1. In the same report they showed that 
females with infantile autism had more evidence of brain 
dysfunction and, more importantly, a higher frequency of affected 
relatives than those of the males with autism. They concluded 
that the females required "a higher dose of genes” to be affected 
with autism. Even though in 1973, Spence et al. [70] did not 
find the 4.77 to 1 ratio of their study to be compatible with a 
model of X-linkage, the work of Tsai et al. [69] suggests that 
at least a subgroup may be affected by this inheritance model. 
Part D_: Serotonin Levels 
Many studies have been done throughout the years to study 
various biochemical parameters in patients with infantile 
autism. The finding of elevated levels of the neurotransmitter 
5-hydroxy tryptophan (serotonin) in peripheral blood of some 
patients with autism is interesting, although its significnace 
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remains unclear [71]. The original description was made, in 1961, 
by Schain et al. [72], They studied a group of mentally retarded 
autistic children and found that six of the 23 patients had 
significantly elevated serotonin levels. Many years later Young 
et al. [71] of the Yale Child Study Center restudied this group 
after the removal of those patients with conditions known to be 
associated with hyperserotonemia or mi sclassified as autistic. 
The results still showed that a significant proportion of the 
autistic patients had elevated serotonin levels. This finding 
has been replicated in other studies [73,74], There is virtually 
no information in the literature on serotonin levels in fragile X 
males or fragile X males with infantile autism. 
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CHAPTER THREE: The Fragile _X Syndrome and Infantile Autism 
Part A^: X-Linked Mental Retardation and Verbal Disabilities 
In 1974, Lehrke [75] found that a significant difference 
existed between the verbal and performance abilities in his group 
of males affected by nonspecific X-linked mental retardation. He 
postulated that the genes responsible for the X-linked mental 
retardation also explained their verbal disabilities. Similarly, 
Jennings et al. [28] had noted that over one-half of the 
published families with X-linked mental retardation were 
described as having significant or excessive verbal 
disabilities. Some of these families had the fragile X 
syndrome . 
In 1980, however, Herbst [48] did not find any difference 
between the verbal and performance IQs in a population of 
patients with X-linked mental retardation. Recently, in a report 
to the International Workshop on the Fragile X and X-linked 
Mental Retardation, Chudley [76] discussed his results on the IQ 
testing of 29 males with the fragile X syndrome. Likewise, his 
group found only a small difference (five points) between verbal 
and performance IQ in this population. It would appear that the 
association between verbal disabilities and X-linked mental 
retardation has mainly an historical value. 
Another area of speech-language function in fragile X males 
19 

has received attention. Some authors have claimed to recognize a 
distinct speech pattern [77-79], described as "repetitive jocular 
speech" [77], in males affected by the fragile X syndrome. These 
reports were of an anecdotal nature since little speech testing 
data were given. In 1979, Howard-Peebles et al. [80] studied 
the language deficiency in five families with X-linked mental 
retardation, including two families with the fragile X syndrome. 
They studied several aspects of language function and 
production. The results were notable for a generalized language 
deficiency and articulation defects similar to those found in 
other forms of mental retardation. Although the number of 
patients was small, they concluded that the "verbal studies 
employed showed little promise as a tool of differentiating 
X-linked verbal disabilities." Future studies of fragile X 
patients may someday provide answers. 
Part 13: Fragile X. and Infantile Autism 
In 1980, Turner et al. [77] noted in their study that one of 
the 25 males with fragile X syndrome had been diagnosed as 
autistic. However, Brown et al. [81] are given credit for first 
emphasizing an association of the fragile X syndrome and 
infantile autism some two years later. They reported four males 
with the fragile X syndrome who had features corapatable with 
infantile autism, although not adhering directly to the DSM-III 
[58] criteria. All of the patients were ascertained because of 
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either a family history of mental retardation or the feature of 
macroorchidism. This report was soon followed by that of Meryash 
et al. [82]. They described a six year old boy with severe 
mental retardation, the fragile X chromosome, and behavioral 
criteria meeting those of the DSM-III [58] for infantile autism. 
This child was tested because of a family history of mental 
retardation. Three other such case reports can be found in the 
literature including: Brown et al. [83], in 1982, one additional 
male; Gillberg [84], in 1983, a set of monozygotic triplets; and 
August [85], in 1983, two brothers. Also in 1983, Levitas et 
al. [86], reported that autistic features were found in six of 
their ten fragile X males. The six met the DSM-III [58] criteria 
of either infantile autism or infantile autism, residual state. 
For the latter, he offered the results of psychometric testing 
done at the time of diagnosis to confirm the presence of autism. 
A two year old boy was diagnosed in this study because he had the 
feature of mental retardation or developmental delay. No mention 
was made of features such as macroorchidism or a family history 
of mental retardation that might have led the author to suspect 
the fragile X syndrome. Two other reports of large series of 
males with the fragile X syndrome have noted the presence of 
infantile autism in a significant proportion of their 
populations. Fryns et al. [23] in 1983, reported infantile 
autism in four of 16 males with the fragile X syndrome and Rhoads 
et al. [87] in 1984, in three of 17. These two studies noted the 
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occurrences of infantile autism but did not discuss the 
diagnostic criteria used. This makes the significance of these 
proportions difficult to evaluate. 
Part C: Study Goals 
Infantile autism is a disorder with a large number of 
etiologies, of which the fragile X syndrome has been implicated 
as one [67]. It is apparent that a subpopulation of patients with 
infantile autism show genetic influences [64,67] and the large 
excess of males with infantile autism is also well documented 
[69]. The idea that the fragile X syndrome with features of 
infantile autism could explain part of the male excess in 
infantile autism is straightfoward and was noted by Gillberg 
[84] , in 1983. 
In August, 1982, this study was begun to determine the 
prevalence of the fragile X syndrome in a population of mentally 
retarded autistic males. This study was the logical next step in 
evaluating a possible association of the fragile X syndrome and 
infantile autism and the extent of this association. 
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CHAPTER Four: Materials and Methods 
Part _A: Patient Selection 
All patients in the study are from the Southbury Training 
School, a residential state institution with approximately 1,200 
mentally retarded persons, located in Southbury, Connecticut. 
A computer search of the medical records of the Southbury 
Training School revealed that 147 patients carried the diagnosis 
of infantile autism. There were 42 females and 105 males. The 
medical records of the males were examined in detail with regard 
to maternal, neonatal, and early childhood medical and 
developmental histories. This review was done to remove those 
patients who had another plausible explanation for their autistic 
features and to assure that the histories available were 
consistent with the DSM-III [58] criteria. This was the only 
requirement for entry into this study. The explanations for the 
exclusion of the males from the original computer list are in 
Table 3. The frequency distribution of the severity of mental 
retardation was similar for both groups and can be found in Table 
4 . 
To meet the goals of the study it was decided that 40 to 50 
autistic males should be screened for the fragile X syndrome. 
After the medical record review 48 males were selected. One 
patient was on placement and could not be located. Thus, a total 
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of 47 males were entered into the study. The chromosomal studies 
were considered part of the diagnostic work for the mental 
retardation and were requested by the physicians responsible for 
the mendical care at the Southbury Training School. 
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Table 3 
Reasons for exclusion of cases (N = 57) from this study. 
No . of Cases 
1. Prenatal infection 2 
2. Intrauterine maldevelopraent 3* 
3. Injury at parturition 4 
4. Prolonged neonatal anoxia 4 
5. Major illness starting in neonatal 
period 7 
6. Major illness or injury prior to 18 
months of age with subsequent change 
behavior 7 
7. Severe neurologic abnormalities 15 
8. History insufficient or incompatible 9 
9. Diagnosis of childhood schizophrenia 5 
10. Combination of above 1** 
* - 2 of 3; pregnancies complicated by severe toxemia 
1 of 3; child small for gestational age 
** - combination of 3 and 5 
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Table 4 
Frequency distribution of degree of mental retardation in the 
cases considered for this study. 
Scores of 
available 
Stanford 
from 98 
-Binet IQ testing from 
of 105 cases. 
medical records 
(IQ range) 
Borderline 
(85-68) 
Mild 
(68-52) 
Moderate 
(52-36) 
Severe 
(36-20) 
Profound 
(<20) 
Included *(N=45) 0 2 8 17 18 
Excluded **(N=53) 0 3 6 16 28 
Total (N-53) 0 5 14 33 46 
* - Data available for 45 of 47 cases 
** - Data available for 53 of 57 cases 
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Part _B: Cytogenetic Techniques 
Peripheral lymphocytes were obtained for culture in the 
following manner. Two tubes of 5 to 7 cc. of whole blood were 
drawn from each patient through a 21 gauge needle into 
heparinized vacutainer tubes. Transport time back to the 
laboratory was 2 to 6 hours. Approximately 2 cc. aliquots of 
whole blood were drawn out of the vacutainer tubes through a 20 
gauge needle into two 3 cc. syringes. The red blood cells were 
allowed to settle and 0.3 cc. of the white blood cell/plasma 
suspension was placed in the appropriate culture media. 
The lymphocyte culture media used for the fragile X testing 
was a low folate, low thymidine media that was capable of 
supporting lymphocyte growth and replication. These conditions 
were obtained by mixing 100 cc. of Medium 199 (GIBCO cat. 
#320-1153), 2 cc. of fetal calf serum (previously tested for 
allowing fragile X expression), 1 cc. of 200 mM L-glutaraine 
(GIBCO cat. #320-5039), and 1 cc. of a Penicillin (5000 
units/ml) - Streptomycin (5000 ug/ml) mixture (GIBCO cat. 
#600-5075). The pH of the final solution was in the range of 7.4 
to 7.6. This solution was divided into 12 cc. aliquots and 
placed in 1 ounce "Brockway" glass bottles. 
Lymphocytes were stimulated to undergo mitosis by the 
addition of 0.1 cc. of the mitogen, phytohemagglutinin (Wellcome 
Reagents Ltd.). The culture was then placed in an incubator at 37 
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degrees Centigrade and kept at a 45 degree angle with the caps 
tightly sealed in order to maintain the proper carbon dioxide 
concentration and pH. After 96 hours of growth, metaphase arrest 
was obtained by the addition of 0.12 cc. of colcemid (GIBCO 
cat. # 120-5211), which provided a final concentration of 0.01 
ug/ml, 30 minutes prior to harvesting. 
For harvesting, each culture was placed in a 15 cc graduated 
centrifuge tube and spun at a setting of 1000 RPM on a table-top 
centrifuge for 8 minutes. The pellet and approximately 0.1 cc. 
of supernatant were saved. The remainder of the supernatant was 
aspirated. The pellet was then resuspended and swelling of the 
cells was achieved by the addition of hypotonic (0.075M) KC1 
prewarmed to 37 degrees Centigrade. The first few drops were 
added slowly and a final volume of between 4 and 7 cc. was 
obtained. This method of swelling the cells aided in the later 
spreading of the chromosomes on the microscope slides. The 
harvested cells were returned to the incubator for 5 minutes and 
then recentrifuged . This and all other centrifugations were 
performed at the setting and time described previously. All but 
the pellet and an equal volume of supernatant were removed. Then 
8 to 10 cc. of fixative, 3:1 methanol: glacial acetic acid by 
volume, was added and this was allowed to sit for 15 minutes. 
The fixative was made fresh and placed in the freezer before each 
use. Centrifugation was again performed and the supernatant 
removed. This fixation step was repeated until the pellet was 
28 

white and the supernatant clear. This was done to remove the red 
blood cell debris. The pellet was stored at -10 degrees 
Centigrade in 5 cc. of fixative in disposable glass tubes and 
capped with a cork. 
To allow examination of the raetaphase chromosomes from the 
lymphocytes, slides were prepared. Each box of new glass slides 
was cleaned and chilled in deionized water and stored in the 
refrigerator. The cells from the freezer were centrifuged and 
the supernatant removed. Then 0.1 - 0.2 cc. of the resuspended 
pellet was dropped onto a glass slide which was held at a 30 
degree angle. The slide was then air-dried on a hot plate for 15 
seconds and labeled. These microscope slides were made one week 
prior to staining. 
Wright staining without trypsin pretreatment was performed on 
all slides. The slides were scanned at 125X and appropriate 
raetaphase spreads then examined at 1250X. A count was made to 
assure that all 46 chromosomes were present in each spread. Then 
the unbanded chromosomes were closely examined for any 
abnormality in staining which could represent a gap, break, or 
other manifestation of a fragile site. All abnormalities were 
recorded. The presence of chromosomal breakage in greater than 
10% of the complete metaphase spreads demonstrated that the 
proper culture conditions had been obtained. A minimum of 40 
unbanded and 15 Giemsa banded diploid sets of chromosomes were 
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studied for the presence of the fragile X site. The Giemsa 
banding was part of the routine karyotyping done on all the 
patients in this study. This was done by other members of Dr. W. 
R. Breg’s laboratory and will not be discussed in detail. 
Any abnormality that was possibly a fragile X site was 
photographed and investigated further. The chromosomes were 
destained by placing the slides sequentially in the following 
solutions: 70% ethanol for 2 minutes; 70% ethanol for 2 minutes; 
95% ethanol with 1% HC1 for 2 minutes; and 100% methanol for 2 
minutes. To allow better identification of the chromosomes they 
were banded by pretreatment with trypsin in a 0.9% NaCl 
solution. The slide was again stained with Wright’s stain and 
the chromosomal spread in question reexamined at 1250X. The 
destaining, trypsin treatment, and Wright staining were 
sequentially repeated until positive identification of the 
chromosome was possible. Any patient found to have >4% of the 
lymphocytes expressing the fragile X site was restudied on an 
entirely new blood sample. This was done to establish the 
frequency of the fragile X expression and to confirm the 
diagnosis of the fragile X syndrome. 
Some clinical data were obtained by other members of Dr. 
Breg’s laboratory. Physical examinations, including 
anthropometric measurements, of the males diagnosed as having the 
fragile X syndrome was done. Information on family members of 
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these patients was obtained whenever possible and cytogenetic 
studies and genetic counseling offered. 
Dr J. Leckraan of the Yale Child Study Center conducted a 
pilot study on serotonin levels in males with the fragile X 
syndrome. This study tested a group of males with the fragile X 
syndrome, a group with infantile autism, and a normal control 
group. The patients from this prevalence study contributed to 
the first two groups and provided the only patients with both 
infantile autism and the fragile X syndrome. 
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CHAPTER FIVE: Results 
A total of 47 males were selected for this study. Prior to 
the medical history review, seven autistic males from the 
original list of 105 had been tested for the fragile X syndrome 
by other members of Dr. Breg’s laboratory. Four of these seven 
males were selected for inclusion in this prevalence study 
without regard to the prior cytogenetic studies, since they met 
the stated criteria. One of these four males had been found to 
have the fragile X syndrome. Of the remaining 43 males, three 
were found to have the fragile X site in >4% of their peripheral 
lymphocytes on two separate samples. In addition, one male 
demonstrated the fragile X site in one of 65 metaphase spreads, 
however, this did not meet the cytogenetic requirements of the 
fragile X syndrome. All other individuals were found to have no 
fragile X sites. All 47 males were found to have a normal 46,XY 
karyotype and a greater than 10% rate of non-specific background 
chromosomal breakage, an indication of proper culture 
conditions. The four patients found to have the fragile X 
syndrome were case records X-10, X-57, 1-11, and X-123. One 
example of the fragile X site from each patient may be found in 
Figures 1 - 4. 
The clinical features found (See Table 5) in these four males 
were typical of the phenotypic abnormalities reported in adult 
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males with the fragile X syndrome. The examiners felt that these 
patients had long narrow faces and protruding ears. On objective 
examination all four males had significant macroorchidism and 
large ears. In one case the raacroorchidism was unilateral. They 
were all mentally retarded with a range from mild to profound. 
Only one of the four was found to have a family history of mental 
retardation. 
Dr. Leckman (personal communication) measured whole blood 
serotonin concentrations in a total of 17 males with the fragile 
X syndrome. Overall, 18% or three of these 17 males had 
hyperserotoneraia. As was expected, 38% of the autistic group and 
7% of the control group had hyperserotonemia. The four autistic 
fragile X males had a wide range of serotonin levels with one 
being elevated. The numbers were too small to draw any 
conclusions, but, the feature of autism in the fragile X male did 
not appear to be related to any distinct whole blood serotonin 
level . 
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Table 5 
Fragile X Patients 
X-10 X-57 1-11 X-123 
Age (years) 36 34 31 41 
% Fragile X 32 68 56 32 
IQ (Stanford-Binet) 33 56 32 20 
*a R. Testicular Vol.(ml)34.6 45.3 74.2 50 
*a L. Testicular Vol.(ml)19.7 50.2 58.6 38.5 
* b Mean Testicular Vol. 27.1 47.8 67.4 44.2 
^ c Ear length (R/L)(mm) 70/70 72/70 75/72 . 5 75/75 
* c Ear width (R/L)(mm) 50/45 50/50 50/48 45/45 
Family History yes * d no*e n o * f adopted 
*a Length and width were 
Volume = (3.14/6) X (L 
measured. 
ength) X (W i d t h) X (Width) [34] 
*b = R. Testicular Volume + L. Testicular Volume X 0 .5 
* c Normal values for ear 
Right Length Mean 62. 
Left Length Mean 62. 
Right Width Mean 50. 
Left Width Mean 50. 
measurement 
2 Standard 
4 Standard 
2 Standard 
2 Standard 
in adult white 
Deviation 3.5 
Deviation 3.5 
Deviation 3.9 
Deviation 4.2 
males [88]: 
*d See Appendix B for family pedigree 
*e See Appendix C for family pedigree 
*f The family did not respond to request for information. 
34 

Figure J_ 
- 35 

Figure 2_ 
X~S7 
1 
36 

Figure 3 
- 37 - 

Figure 4_ 
Pf OiyW C>0 
< 
V 
\u 
/ 
I '* 
/ 
/ 
* 
jT'S Ans 
\ 
V-H *» 
V ♦ 
V* 
/ f 
.'ui 
s * '* 
& :*y 
38 

CHAPTER Six: Discussion 
In some of the case reports which had found the fragile X 
syndrome in patients with infantile autism there was speculation 
that a significant frequency of association between these two 
disorders might exist [81,83]. This study was designed to provide 
prevalence data to evaluate the extent of this association. The 
results showed that four of 47 mentally retarded autistic males 
had the fragile X syndrome. This gives a prevalence of 8.5% in 
this population, which included seven autistic males in addition 
to those previously reported in the Southbury Training School 
group by us in 1984, Watson et al. [89]. That study is, to my 
knowledge, the only formally published prevalence study of the 
fragile X syndrome in a group with infantile autism and mental 
retardation . 
Little other data are available to be used as as comparison 
to the 8.5% prevalence found in this group. Watson et al. [89] 
studied an additional 35 autistic males, not from the Southbury 
Training School, for the fragile X syndrome but found none. As a 
group they were less retarded than the group reported here, 
Watson (personal communication). Kahkonen et al. [25] reported 
that none of their 19 mentally retarded males with the diagnosis 
of infantile psychosis had the fragile X syndrome. The 
diagnostic term infantile psychosis has been one of many terms 
used for infantile autism [90]. Some of these patients may well 
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have met the DSM-III [58] criteria for infantile autism. The 
results of three unpublished reports by separate investigators 
who screened autistic males for the fragile X syndrome were 
reported to the International Workshop on the Fragile X and 
X-linked Mental Retardation by Leckman, Turner, Ch u d1e y and 
Mikkelson [76]. A total of three cases were found in the 106 
autistic patients studied . No information was available on 
selection criteria or other features of those groups that could 
explain the higher prevalence found in our group studied at the 
Southbutry Training School. 
A possiblity to be considered was that the prevalence found 
in this study was related only to the feature of mental 
retardation and was independent of infantile autism. All of the 
patients in this study were mentally retarded in addition to 
being autistic. However, the 8.5% prevalence of the fragile X 
syndrome found in this autistic, mentally retarded population was 
higher than the prevalence found in 7 of the 8 large studies 
[18,20-26] of mentally retarded males, but may well have included 
some who had the additional feature of infantile autism (See 
Table 1 at the end of chapter 1). Some of these studies used 
additional selection criteria such as macroorchidism [22] or a 
family history of mental retardation [20,23] to increase the 
likelihood of finding the fragile X syndrome. Still, only the 
study by Carpenter et al. [20] found a higher prevalence (9.2%). 
A study on the prevalence of the fragile X syndrome in a group of 
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mentally retarded males who lack the feature of infantile autism 
would provide a good comparison group. No study of this type has 
been performed, to my knowledge. 
One possible explanation for the high prevalence of the 
fragile X syndrome in this report may be the method of patient 
selection. The patients studied here had no evidence by history, 
laboratory, or physical examination of an environmental or known 
biologic insult that could have explained their infantile 
auitsm. This may have increased the probability of a genetic 
etiology. A somewhat similar method was used by Herbst and 
Miller [15] to allow an accurate estimation of the frequency of 
X-linked mental retardation in British Columbia. 
The results from this study demonstrated that when the 
additional feature of infantile autism was applied to a group of 
mentally retarded males it led to the finding of a higher 
prevalence of the fragile X syndrome. The number of patients in 
this study and the effects of different selection processes make 
the results of this study somewhat difficult to compare to 
others. However, the results of this study appear to be 
suggestive that an association between the fragile X syndrome and 
infantile autism exists in mentally retarded males. 
A genetic influence in infantile autism has also been shown 
by the twin studies of Folstein & Rutter [64] and Ritvo et al. 
[ 67] . The recurrence rate for the development of autism amoung 
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siblings has been shown to be approximately 2% [61]. Although 
this rate is 50 times higher than in the general population, it 
might have been considered relatively small. For this reason, 
genetic etiology studies have not been thought to have a major 
role in the syndrome of infantile autism. 
It is apparent from the results of this study and several 
previously published case reports [81-86] that the etiology for a 
proportion of males with infantile autism is the fragile X 
syndrome. This is a most important subgroup to identify for a 
number of reasons. The recurrence rate in this subgroup for the 
development of mental retardation and/or infantile autism is 50% 
for a male s i b 1 ing and the improving capabi lities of prenatal 
diagnosis [91] o f the fragile X site may provide valuable 
information to a family. Also, early reports have been reviewed 
[92] and suggest a possible form of treatment or improvement with 
folate therapy, although this is not proven. Lastly, Levitas et 
al. [86] suggest that the autistic fragile X male may benefit 
from early intervention with special education. 
There is a wide diversity of opinion regarding the use of 
fragile X testing for autistic males. Brown et al. [81,83] have 
recommended this testing for all males with autism of unknown 
etiology. They noted [83], however, that this might overwhelm 
the capabilities of many cytogenetic laboratories because of the 
number of people that would need to tested. The yield from such 
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a large screening would likely be very low but the advantages of 
such an approach are clear. For the many reasons noted earlier, 
this would allow the diagnosis of the fragile X syndrome to be 
made in those persons who may not have all its typical features. 
This is especially true for children who are too young to have 
the feature of macroorchidism, the severity of their mental 
retardation appreciated, or an affected brother. On the other 
hand, Meryash et al. [82] and August [85] advise fragile X 
testing for families with two or more autistic individuals and an 
X-linked pattern of inheritance. This would have a better 
percent yield then the policy of Brown et al. [83], but, would 
result in the medical community missing the diagnosis of the 
fragile X syndrome in many cases. 
This study found the prevalence of the fragile X syndrome in 
a group of autistic mentally retarded males to be 8.5% and 
demonstrates that fragile X testing would be a valuable test in 
all males with infantile autism of unknown etiolgy who are 
mentally retarded. The population at the Southbury Training 
School represents but one part of the entire autistic 
population. It is probably rare for males with the fragile X 
syndrome to have a normal intelligence and macroorchidism is a 
reliable phenotypic feature in the adult [43], Fragile X testing 
is therefore probably not necessary in the autistic postpubertal 
male unless they have the features of mental retardation or 
macroorchidism, with or without a family history of mental 

retardation, although no study on this question has been 
performed. The question of whether or not to test every autistic 
male for the fragile X syndrome is difficult to answer because of 
the very early age that autism is diagnosed. At the present 
time, given the many potential advantages to the family and 
perhaps to the child for establishing the diagnosis, conservative 
medical management should be to test all male children with 
infantile autism of unknown etiology for the fragile X syndrome. 
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Appendix A_ 
National Society for Children 
Definition of the Syndrome of 
Essential features: Autism is a behaviorally 
defined syndrome. The essential features are typically 
manifested prior to 30 months of age and include' 
1 Disturbances of developmental rates and sequences 
Normal coordination of the three developmental 
pathways_(motor.-social-adaptive. cognitive) is dis¬ 
rupted Delays, arrests, and/or regressions occur 
among or within one or more of the pathways a) 
within the motor pathway (eg. gross motor 
milestones may be normal, while fine motor 
milestones are delayed); b) between pathways (eg. 
motor milestones may be normal, while social-adap¬ 
tive and cognitive are delayed); c) arrests, delays, and 
regressions (eg. motor development may be normal 
until age 2 when walking stops; some cognitive skills 
may develop at expected times, while others are 
delayed or absent, imitative behavior and/or speech 
may be delayed in onset until age 3. followed by 
rapid acquisition to expected developmental level) 
2 Disturbances of responses to sensory stimuli. There 
may be generalized hyperreactivity or hyporeactivitv. 
and alternation of these two states over periods 
ranging from hours to months. For example, a) visual 
symptoms These may be close scrutiny of visual 
details apparent nonuse of eye contact, staring, pro¬ 
longed regarding of hands or objects, attention to 
changing levels of illumination; b) auditory symp¬ 
toms These may be close attention to self-induced 
sounds, nonresponse, or overresponse to varying 
levels of sound, c) tactile symptoms. These may be 
over- or underresponse to touch, pain, and tem¬ 
peratures prolonged rubbing of surfaces, and sen¬ 
sitivity to food textures, d) vestibular symptoms 
These may be over- or underreactions to gravity stim¬ 
uli. whirling without dizziness, and preoccupation 
with spinning objects; e) olfactory and gustatory 
symptoms These may be repetitive sniffing, specific 
food preferences, and licking of inedible objects; f) 
proprioceptive symptoms. These may be posturing, 
"darting-lunging movements, hand flapping, ges¬ 
ticulations. and grimaces. 
3. Disturbances of speech, language-cognition, and 
nonverbal communication. Symptoms may include. 
and Adults with Autism: 
Autism. 
a) speech (eg. mutism, delayed onset, immature syn¬ 
tax and articulation, modulated but immature inflec¬ 
tions). b) language-cognition (eg. absent or limited 
symbolic capacity; specific cognitive capacities such 
as rote memory and visual-spatial relations intact 
with failure to develop the use of abstract terms, 
concepts, and reasoning immediate delayed, nega¬ 
tive echolalia with or without communicative intent, 
nonlogical use of concepts, neologisms; c) nonver¬ 
bal communication (eg. absence or delayed 
development of appropriate gestures, dissociation of 
gestures from language, and failure to assign sym¬ 
bolic meaning to gestures). 
4 Disturbances of the capacity to relate appropriately 
to people, events, and objects, manifested by a 
failure to develop appropriate responsivity to people 
and assignment of an appropriate symbolic meaning 
to objects. For example, a) people absence, arrests 
and/or delays of a smiling response, stranger anxiety 
anticipatory response to gestures, playing ''peek-a- 
boo." playing "patty-cake." and waving "bye-bye." 
reciprocal use of eye contact and facial responsivity. 
and appropriate reciprocal responsiveness to physi¬ 
cal contact, a failure to develop a relationship with 
significant caretakers or an excessive reliance on 
caretakers. For example, caretakers may be treated 
indifferently interchangeably, with only mechanical 
clinging, or with panic on separation. Cooperative 
play and friendships'fusually appearing between 
ages 2 and 4) may not develop Expected responses 
to adults and peers (usually appearing between ages 
5 and 7) may develop, but are superficial, immature, 
and only in response to strong social cues, b) objects; 
absent, arrested and/or delayed capacities to utilize 
objects and/or toys in an age-appropriate manner 
and/or to assign them symbolic and/or thematic 
meaning Objects are often used in idiosyncratic, 
stereotypic, and/or perseverative ways. Interference 
with this use of objects often results in expressions of 
discomfort and/or panic; c) events there may be a 
particular awareness of the sequence of events and 
disruption of this sequence may result in expressions 
of discomfort and/or panic. 
Taken from Freedman et al. [90], 
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Appendix 13 
This is the family pedigree from patient X-10. The details from 
the pedigree may be found on the following page. 
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Individual 
ID 
Sex Age 
DOB 
IQ MnrfX) cells 
totai cells scored 
Comment s 
II-2 F 1Q22 
1 
i 
iNorma lL 0/61 Declined retest 
II-3 1 £ 
1 Norma 
I 
1 nt 
I 
II-4 F Norma 1 nt 
III-l 
1 
Pr Reportedly Down S 
Seating confirms' 
TII-2 1043 33 15/50 Autistic 
III-3 t? 1^50 Norma 1 23/110- 
I11-4 I'i l°5c n t ^ C * id/ ^ re ^ 
institution in 
* * c(*; , 7 s- i r 
Fragile X by hist 
III-5 ■n Norma I nt 
t 7 r _ U I . _ i 
,j Dull nt 
III-7 F Norma 1 nt 
111-8 M Re tar led nt Fragile X by hist 
IV-1 M Norma 1 nt 
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Appendix C 
This is the family pedigree from patient X-57. The patients 
mother was found to be a carrier. There was no other family 
history of mental retardation or presence of the fragile X site. 
Individucl 
ID 
Sex A a e ■o IQ Mn r fXI coll? 
tocai cells scored 
Cornr.cn ts 
- 
1-3 | M n t 
I-4 F Norma 1 nc lr na va i. la b le 
I" -2 
■ 
Nor rr.3 1 0 '50 
::-3 F Norma L 5/100 Also mosaic for src 
ma rker 
m-i M 1950 10 5 6 01/150 Autistic 
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